Development of a Tacrolimus-loaded carboxymethyl chitosan scaffold as an effective 3D-printed wound dressing
Journal of Drug Delivery Science and Technology(2023)
摘要
Infection and lack of angiogenesis are considered to be the main factors slowing the healing process in chronic wounds. To address these challenges, bioactive, multi-functional wound dressings have received a lot of attention. A 3D-printed carboxymethyl chitosan scaffold loaded with Tacrolimus (TAC-CMC) was introduced and tested as a potential bioactive dressing for chronic wound healing. Following topographical and physical characterization of the wound dressings, the release profile of Tacrolimus from the TAC-CMC scaffold was investigated. In vitro evaluation revealed that both carboxymethyl chitosan scaffold (CMC) and TAC-CMC scaffolds were biocompatible, but only TAC-CMC causing an increase in the secretion of vascular endothelial growth factor (VEGF) from fibroblasts. Disk diffusion test of the fabricated scaffolds demonstrated a significant antibacterial activity of TAC-CMC scaffold against both E. Coli and S. aureus as Gram negative and positive bacteria, respectively. The in vivo assessments of the bare and bioactive wound dressings have revealed that 7 days post-wounding, wounds treated with the TAC-CMC resulted in a 90.4 ± 2.4% closure rate which was significantly faster than those in the positive control (Comfeel plus®). The histopathological evaluation of the treated and non-treated wounds proved the efficacy of TAC-CMC scaffold in improving angiogenesis, epidermal regeneration, fibroblasts proliferation, and inflammatory responses.
更多查看译文
关键词
Wound dressing,Carboxymethyl chitosan,Tacrolimus,3D-printing,Angiogenesis,Antibacterial
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要